BioVersys AG

BioVersys announces expansion of strategic collaboration with GSK

BioVersys AG announced the expansion of its strategic collaboration with GSK plc to accelerate the clinical development of alpibectir (BVL-GSK098) for the treatment of TB.

Read More →

Page 1 of 1 · Total posts: 1

1